CIRM Funded Clinical Trials

Phase 1/ 2 Study of FRF-001, an AAV-9 Gene Therapy, in Patients with FOXG1 Syndrome (FS)

Disease Area:
Neurological Disorders, Pediatrics
Investigator:
Gai Ayalon
Institution:
FOXG1 Research Foundation
CIRM Grant:
CLIN2-19928 (Pre-Active)
Award Value:
$4,928,664.00
Trial Sponsor:
FOXG1 Research Foundation
Trial Stage:
Phase 1/2
Trial Status:
Launching
Targeted Enrollment:
N/A